Achieve Life Sciences Inc expected to post a loss of 42 cents a share - Earnings Preview

Achieve Life Sciences

12/08/2023 02:42

* Achieve Life Sciences Inc  ACHV.OQ   ACHV.O  is expected
to show
no change in quarterly revenue when it reports  results on
August 14. 
    * 
    * ​Refinitiv's mean analyst estimate for Achieve Life
Sciences Inc
is for a loss of 42 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Achieve
Life
Sciences Inc is $25​, above​ its last closing price of $5.31.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.68       -0.69      -0.50     Beat    27.1
 Dec. 31 2023  -0.77       -0.83      -0.83     Met     0
 Sep. 30 2022  -1.14       -1.13      -1.35     Missed  -19.8​
 Jun. 30 2022  -0.83       -0.83      -1.08     Missed  -29.5
 ​​Mar.        -0.79       -0.81      -0.80     Beat    1.5
 31 2022                                                
 Dec. 31 2021  -0.70       -0.69      -0.76     Missed  -9.9​
 Sep. 30 2021  -1.14       -1.11      -0.71     Beat    36.2
 Jun. 30 2021  -1.22       -1.22      -1.53     Missed  -25.2
 This summary was machine generated August 12 at 01:42 GMT.  All
figures in US dollars  unless otherwise stated